a day ago
Chinese Firm Halts Production of Controversial Alzheimer's Drug
A Chinese company that developed the country's first homegrown Alzheimer's disease therapy has suspended production of the drug, a local media report said, casting doubts on the treatment's future nearly five years after its approval.
Shanghai's Green Valley Pharmaceutical Co. informed employees of the production halt in an internal notice at the end of May, Yicai reported Monday, citing a person it didn't identify. The company failed to renew the drug's license and is currently waiting for regulatory review, the outlet reported, citing the source.
